Coffee and chat
'Coffee and Chat' Highlights: Professor Chloe Orkin and Nurse specialist Jonathan Roberts
Two experts in conversation: Professor Chloe Orkin and Nurse specialist Jonathan Roberts share their reflections of long acting injectables in the context of shared decision-making and discussing risks and benefits with patients.
‘Coffee and chat’ full conversations
Professor Chloe Orkin and Nurse Specialist Jonathan Roberts
Professor Chloe Orkin and Nurse specialist Jonathan Roberts share their reflections of long acting injectables in the context of shared decision-making and discussing risks and benefits with patients.
Nurse Consultant Laura Hilton
Nurse Consultant Laura Hilton shares her reflections of long acting injectables in the context of patient adherence and concordance.
REKAMBYS (rilpivirine long-acting injection), including the trademark, is owned by the Janssen Pharmaceutical Companies and used under license by the ViiV Healthcare group of companies. All other trademarks are owned by the ViiV Healthcare group.
PM-GB-CBR-WCNT-250011 v2 | March 2026
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK via the GSK Reporting Tool or on 0800 221441.
